食管癌外科研究的现状与新动向

在中国，食管癌死亡率在男性中位于第四位，在女性中位于第二位。近年来，欧美国家的食管腺癌发生率也有明显上升。食管癌的治疗效果总体不佳，患者接受传统的外科手术后5年生存率在15％-20％左右，但是近年来外科手术方式得到发展和优化，特别是影像学技术的飞速发展和肿瘤分子生物学研究的进展，食管外科走向了个体化治疗的时代。

Surgical treatment for esophageal cancer: current status and future directions

Carcinoma of the esophagus is the second most common cause of cancer- related -death in women, and fourth in men in China. The prevalence rate of adenocarcinoma of esophagus has increased in the western countries recently too. Unfortunately, the treatment result of esophageal cancer is very poor, and only 15% - 20% of all esophageal cancer patients will be alive 5 years after diagnosis. With the development of radiologic techniques and molecular biology, the esophageal cancer patients are given on individualized treatment modality. This paper reviewed several interesting topics, ineluding operation for esophageal cancer, new technologies for pre-operative staging, muhidisciplinary treatment as well some data from the Shanghai Cancer Hospital.